Research graph
References from Prediction of repurposed drugs for Coronaviruses using artificial intelligence and machine learning. Local targets link to admitted publications; unresolved targets remain external evidence.
10.1038/nrmicro.2016.81
10.1038/nrmicro.2016.81 · External reference
Cryo-electron tomography of mouse hepatitis virus: Insights into the structure of the coronavirion
10.1073/pnas.0805270106 · 2009 · External reference
10.1128/jvi.00645-06
10.1128/jvi.00645-06 · External reference
10.1128/jvi.06540-11
10.1128/jvi.06540-11 · External reference
Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan. Emerg
10.1080/22221751.2020.1719902 · 2020 · External reference
10.1016/s0140-6736(20)30251-8
10.1016/s0140-6736(20)30251-8 · External reference
10.1016/s0065-3527(06)66005-3
10.1016/s0065-3527(06)66005-3 · External reference
10.1016/j.febslet.2004.09.009
10.1016/j.febslet.2004.09.009 · External reference
10.1016/j.cell.2020.02.058
10.1016/j.cell.2020.02.058 · External reference
10.1038/nature17200
10.1038/nature17200 · External reference
10.1002/mco2.26
10.1002/mco2.26 · External reference
New understanding of the damage of SARS-CoV-2 infection outside the respiratory system
10.1016/j.biopha.2020.110195 · 2020 · External reference
Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV
10.1038/s41467-019-13940-6 · 2020 · External reference
10.1038/s41422-020-0282-0
10.1038/s41422-020-0282-0 · External reference
Chloroquine is a potent inhibitor of SARS coronavirus infection and spread
10.1186/1743-422x-2-69 · 2005 · External reference
10.1128/aac.03011-14
10.1128/aac.03011-14 · External reference
Chloroquine for the 2019 novel coronavirus SARS-CoV-2
10.1016/j.ijantimicag.2020.105923 · 2020 · External reference
Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2 infection in vitro
2020 · External reference
SARS-CoV-2: Recent Reports on Antiviral Therapies Based on Lopinavir/Ritonavir, Darunavir/Umifenovir, Hydroxychloroquine, Remdesivir, Favipiravir and other Drugs for the Treatment of the New Coronavirus
10.2174/0929867327666200416131117 · 2020 · External reference
Role of lopinavir/ritonavir in the treatment of SARS: initial virological and clinical findings
10.1136/thorax.2003.012658 · 2004 · External reference
Combination therapy with lopinavir/ritonavir, ribavirin and interferon-α for Middle East respiratory syndrome
10.3851/imp3002 · 2016 · External reference
Treatment of Middle East Respiratory Syndrome with a combination of lopinavir-ritonavir and interferon-β1b (MIRACLE trial): study protocol for a randomized controlled trial
10.1186/s13063-017-2427-0 · 2018 · External reference
Triple combination of interferon beta-1b, lopinavir-ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial
10.1016/s0140-6736(20)31042-4 · 2020 · External reference
Lopinavir/ritonavir for the treatment of SARS, MERS and COVID-19: a systematic review
2020 · External reference
Molecular docking and dynamic simulations for antiviral compounds against SARS-CoV-2: A computational study
10.1016/j.imu.2020.100345 · 2020 · External reference
Identification of potential inhibitors against SARS-CoV-2 by targeting proteins responsible for envelope formation and virion assembly using docking based virtual screening, and pharmacokinetics approaches
10.1016/j.meegid.2020.104451 · 2020 · External reference
10.1093/nar/gks450
10.1093/nar/gks450 · External reference
AVP-IC50 Pred: Multiple machine learning techniques-based prediction of peptide antiviral activity in terms of half maximal inhibitory concentration (IC50)
10.1002/bip.22703 · 2015 · External reference
10.1186/s13321-018-0266-y
10.1186/s13321-018-0266-y · External reference
Anti-flavi: A Web Platform to Predict Inhibitors of Flaviviruses Using QSAR and Peptidomimetic Approaches
10.3389/fmicb.2018.03121 · 2018 · External reference
10.3389/fmicb.2020.01858
10.3389/fmicb.2020.01858 · External reference
10.1093/bib/bbaa421
10.1093/bib/bbaa421 · External reference
10.1093/ije/dyaa033
10.1093/ije/dyaa033 · External reference
10.1016/j.scib.2020.12.005
10.1016/j.scib.2020.12.005 · External reference
Mechanisms of action of photodynamic therapy with verteporfin for the treatment of age-related macular degeneration
10.1016/s0039-6257(00)00158-2 · 2000 · External reference
Multifunctional theranostic Pluronic mixed micelles improve targeted photoactivity of Verteporfin in cancer cells
10.1016/j.msec.2016.09.064 · 2017 · External reference
Neurocovid: Pharmacological Recommendations for Delirium Associated With COVID-19
10.1016/j.psym.2020.05.013 · 2020 · External reference
10.3390/ijms21113793
10.3390/ijms21113793 · External reference
Thrombin Inhibition by Argatroban: Potential Therapeutic Benefits in COVID-19
10.1007/s10557-020-07066-x · 2021 · External reference
10.1101/2020.05.23.112235
10.1101/2020.05.23.112235 · External reference
Computational Identification of Inhibitors Using QSAR Approach Against Nipah Virus
10.3389/fphar.2019.00071 · 2019 · External reference
Computational evidence for nitro derivatives of quinoline and quinoline N-oxide as low-cost alternative for the treatment of SARS-CoV-2 infection
10.1038/s41598-021-85280-9 · 2021 · External reference
10.1016/j.rechem.2020.100094
10.1016/j.rechem.2020.100094 · External reference
High-throughput virtual screening of drug databanks for potential inhibitors of SARS-CoV-2 spike glycoprotein
2020 · External reference
10.1021/acs.jproteome.0c00397
10.1021/acs.jproteome.0c00397 · External reference
10.1093/nar/gkaa861
10.1093/nar/gkaa861 · External reference
10.1038/s41598-021-84700-0
10.1038/s41598-021-84700-0 · External reference
10.1093/bib/bbaa300
10.1093/bib/bbaa300 · External reference
10.1016/j.csbj.2020.12.028
10.1016/j.csbj.2020.12.028 · External reference
10.1016/j.csbj.2020.03.025
10.1016/j.csbj.2020.03.025 · External reference
10.1038/s41421-020-0153-3
10.1038/s41421-020-0153-3 · External reference
10.1002/jcc.21707
10.1002/jcc.21707 · External reference
10.1897/01-171
10.1897/01-171 · External reference
AVCpred: an integrated web server for prediction and design of antiviral compounds
10.1111/cbdd.12834 · 2017 · External reference
10.1186/1758-2946-3-33
10.1186/1758-2946-3-33 · External reference
10.1007/978-0-387-30162-4_415
10.1007/978-0-387-30162-4_415 · 2008 · External reference
Machine Learning with Scikit-Learn and Tensorflow: Deep Learning with Python (Random Forests
2019 · External reference
Unresolved reference
2009 · External reference
10.1007/978-1-4020-8265-8_200980
10.1007/978-1-4020-8265-8_200980 · External reference
Unresolved reference
External reference
A support vector machine-recursive feature elimination feature selection method based on artificial contrast variables and mutual information
10.1016/j.jchromb.2012.05.020 · 2012 · External reference
Recursive feature elimination for brain tumor classification using desorption electrospray ionization mass spectrometry imaging
2012 · External reference
RADER: a RApid DEcoy Retriever to facilitate decoy based assessment of virtual screening
10.1093/bioinformatics/btw783 · 2017 · External reference
10.1093/nar/gkr320
10.1093/nar/gkr320 · External reference
10.1093/nar/gkx1037
10.1093/nar/gkx1037 · External reference
10.1002/jcc.21256
10.1002/jcc.21256 · External reference
10.1002/jcc.21334
10.1002/jcc.21334 · External reference
10.1016/j.cell.2020.03.045
10.1016/j.cell.2020.03.045 · External reference
10.1016/j.micpath.2020.104365
10.1016/j.micpath.2020.104365 · External reference
